Ziyang Zhu
Chengdu, 610072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Lactate dehydrogenase A inhibition-induced metabolic reprogramming combined with targeted ceria nanozymes protects against myocardial ischemia-reperfusion injury.
Journal: Biomaterials advances
Published: March 28, 2026
Ferroptosis-Enhanced Radiopharmaceutical Therapy via a Manganese-Based Nanoplatform.
Journal: Molecular pharmaceutics
Published: September 10, 2025
Exploration of a novel quantitative model based on PRIMARY score in the diagnosis of clinically significant prostate cancer using [18F]PSMA PET/CT.
Journal: World journal of urology
Published: April 01, 2025
Iron chelators loaded on myocardiocyte mitochondria-targeted nanozyme system for treating myocardial ischemia-reperfusion injury in mouse models.
Journal: Journal of nanobiotechnology
Published: December 11, 2024
Targeted delivery of Saikosaponin A and doxorubicin via hyaluronic acid-modified ZIF-8 nanoparticles for TNBC treatment: Inhibiting metastasis and reducing cardiotoxicity.
Journal: Biomaterials advances
Published: October 07, 2024
Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery.
Journal: Biomaterials
Published: May 10, 2024
Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation.
Journal: Biomaterials research
Published: January 13, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026